Monthly information related to total number of voting rights and shares composing the share capital - February 29, 2024
06 March 2024 - 4:00AM
UK Regulatory
Monthly information related to total number of voting rights and
shares composing the share capital - February 29, 2024
Monthly information related to total
number of voting rights and shares composing the share capital -
February 29, 2024
Article 223-16 of general regulation
of French Autorité des Marchés Financiers
Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code:
FR001400K4B1- Symbol: PHXM) &
Nasdaq Global Select Market in the United-States (Symbol: PHXM)
Website : www.phaxiam.com
|
Date |
Total of shares composing the share capital |
Total of brut (1)
voting rights |
Total of net
(2)
voting rights
|
|
December 31, 2023 |
6 075 105 |
6 226 982 |
6 226 733 |
|
January 31, 2024 |
6 075 105 |
6 227 002 |
6 226 753 |
|
February 29, 2024 |
6 075 105 |
6 226 951 |
6 226 702 |
(1) Gross voting
rights number (or « theoretical » voting rights) is used
as a basis for calculating the crossing of the threshold. In
accordance with article 223-11 of general regulation of
Autorité des Marchés Financiers,
this number is calculated on the basis of
all shares carrying the single and double voting rights,
including shares without voting rights.
(2) Without treasury
shares.
- CP_Déclaration Droits de Vote 29 02 2024_vENG
Phaxiam Therapeutics (LSE:0QSS)
Historical Stock Chart
From Dec 2024 to Jan 2025
Phaxiam Therapeutics (LSE:0QSS)
Historical Stock Chart
From Jan 2024 to Jan 2025
